SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-17-000551
Filing Date
2017-09-22
Accepted
2017-09-22 16:41:45
Documents
1
Group Members
IBEX ISRAEL FUND LLLPJUSTIN B. BORUS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ibex_bondvax-13g.htm SC 13G 94785
  Complete submission text file 0001079973-17-000551.txt   96455
Mailing Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209
Business Address 3200 CHERRY CREEK SOUTH DRIVE SUITE 670 DENVER CO 80209 303-500-8821
Ibex Investors LLC (Filed by) CIK: 0001531964 (see all company filings)

IRS No.: 331042318 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Subject) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: SC 13G | Act: 34 | File No.: 005-89384 | Film No.: 171097993
SIC: 2836 Biological Products, (No Diagnostic Substances)